Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP518525.RA_GHPrWZ_W_npEkhUHrCXTHxoTfA_CPv_3rPg_AG-iBI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP518525.RA_GHPrWZ_W_npEkhUHrCXTHxoTfA_CPv_3rPg_AG-iBI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP518525.RA_GHPrWZ_W_npEkhUHrCXTHxoTfA_CPv_3rPg_AG-iBI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP518525.RA_GHPrWZ_W_npEkhUHrCXTHxoTfA_CPv_3rPg_AG-iBI130_provenance.
- NP518525.RA_GHPrWZ_W_npEkhUHrCXTHxoTfA_CPv_3rPg_AG-iBI130_assertion description "[The ZMYM2-FGFR1 (formerly known as ZNF198-FGFR1) fusion kinase induces stem cell leukemia-lymphoma syndrome (SCLL), a hematologic malignancy characterized by rapid transformation to acute myeloid leukemia and T-lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP518525.RA_GHPrWZ_W_npEkhUHrCXTHxoTfA_CPv_3rPg_AG-iBI130_provenance.
- NP518525.RA_GHPrWZ_W_npEkhUHrCXTHxoTfA_CPv_3rPg_AG-iBI130_assertion evidence source_evidence_literature NP518525.RA_GHPrWZ_W_npEkhUHrCXTHxoTfA_CPv_3rPg_AG-iBI130_provenance.
- NP518525.RA_GHPrWZ_W_npEkhUHrCXTHxoTfA_CPv_3rPg_AG-iBI130_assertion SIO_000772 21527531 NP518525.RA_GHPrWZ_W_npEkhUHrCXTHxoTfA_CPv_3rPg_AG-iBI130_provenance.
- NP518525.RA_GHPrWZ_W_npEkhUHrCXTHxoTfA_CPv_3rPg_AG-iBI130_assertion wasDerivedFrom befree-20140225 NP518525.RA_GHPrWZ_W_npEkhUHrCXTHxoTfA_CPv_3rPg_AG-iBI130_provenance.
- NP518525.RA_GHPrWZ_W_npEkhUHrCXTHxoTfA_CPv_3rPg_AG-iBI130_assertion wasGeneratedBy ECO_0000203 NP518525.RA_GHPrWZ_W_npEkhUHrCXTHxoTfA_CPv_3rPg_AG-iBI130_provenance.
- befree-20140225 importedOn "2014-02-25" NP518525.RA_GHPrWZ_W_npEkhUHrCXTHxoTfA_CPv_3rPg_AG-iBI130_provenance.